← SynDRA
SPERMIDINE
SynDRA canonical compound SYN0001173 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | KCNJ4 | TXNRD1 |
|---|
| Mechanism of action | glutamate receptor modulator |
|---|
All known targets
Mechanisms of action (all sources)
- KCNJ4 ANTAGONIST
- glutamate receptor modulator
- TXNRD1 INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- CA5B
- CA1
- PKM
- CA14
- CA2
- CA4
- CA5A
- CA6
- CA7
- CA9
- SLC47A1
- MTOR
- PAOX
- POLK
- SLC22A4
- ALOX15
- KAT2A
- SLC47A2
- SMN1
- TDP1
- THPO
- LMNA
- CYP2C9
- F13A1
- EHMT2
- CYP3A4
- CYP2D6
- ALOX15B
- CYP2C19
- CYP1A2
- CA3
- CA12
- ATAD5
- APEX1
- TSHR
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- ACM1
- ACM5
- CP1A2
- CP2C9
- KSYK
- NSD2
- PAFA
- SYK
- TPO
Cross-references
Synonyms
- Spermidin
- UNII-U87FK77H25
- BRN 1698591
- AI3-26636
- EINECS 204-689-0
- CHEMBL19612
- CHEBI:16610
- ATHGHQPFGPMSJY-UHFFFAOYSA-N
- U87FK77H25
- MFCD00008229
- Spermidine hydrochloride
- NSC528399
- 1pot
- Aminopropylbutandiamine
- N-(4-Aminobutyl)-1,3-diaminopropane
- Spectrum_000005
- Tocris-0959
- ACMC-20ajn3
- AC1L1AQB
- Spectrum2_000874
- Spectrum3_000977
- Spectrum4_001101
- Spectrum5_001561
- Lopac-S-2501
- Biomol-NT_000212
- bmse000116
- bmse000951
- bmse000955
- Spermidine 0.1 M solution
- Lopac0_001047
- SCHEMBL15618
- BSPBio_002613
- KBioGR_001542
- KBioSS_000345
- 4-04-00-01300 (Beilstein Handbook Reference)
- DivK1c_001007
- SPBio_000947
- Spermidine, >
- =99% (GC)
Look up SPERMIDINE in the interactive SynDRA portal →